SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
7 references·7 citing·41 second hop
Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. (2002)Exploring generic drug use behavior: the …The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision (2000)The Importance of Doctors’ an…Physicians' Attitudes About Prescribing and Knowledge of the Costs of Common Medications (2000)Physicians' Attitudes About P…Moral hazard in physician prescription behavior (2000)Moral hazard in physician pre…Financial Incentives And Drug Spending In Managed Care (1999)Financial Incentives And Drug…The Importance of the Physician in the Generic versus Trade-Name Prescription Decision (1998)The Importance of the Physici…The doctor as double agent: Information asymmetry, health insurance, and medical care (1991)The doctor as double agent: I…Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals (1988)Persuasion or Information? Pr…Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians (2015)Improving Adherence to Therap…Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark (2014)Regulation of pharmaceutical …Exploring the impact of operating model choice on the governance of inter-organizational workflow: the U.S. e-prescribing network (2012)Exploring the impact of opera…Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand (2010)Evaluating pharmacists’ views…A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance (2010)A nationwide study on generic…Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization? (2009)Is There a Relationship Betwe…What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice (2007)What’s in a Name? Use of Bran…Health, economics, and health economics (1982)Financial Incentives for Physicians in HMOs (1987)The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization (1990)What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries (2008)Cost-sharing: effects on spending and outcomes. (2010)Econometric Measurement of the Duration of Advertising Effect on Sales (1976)Optimal Advertising and Optimal Quality (1976)Product differentiation advantages of pioneering brands (1980)Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry (2000)Do Pharmaceutical Sales Respond to Scientific Evidence? (2002)Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2011)Crime and Punishment: An Economic Approach (1968)A re-examination of the meaning and importance of supplier-induced demand (1994)Chapter 2 An overview of the normative economics of the health sector (2000)Uncertainty and The Welfare Economics of Medical Care (2001)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)A Computationally Efficient Quadrature Procedure for the One-Factor Multinomial Probit Model (1982)The economics of moral hazard: comment (1982)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing (2003)Physician Agency and Adoption of Generic Pharmaceuticals (2012)Historical Origins of the Health Belief Model (1974)Latent variable models: An introduction to factor, path, and structural analysis (1987)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)On the Pooling of Time Series and Cross Section Data (1978)Designing Economic Agents that Act Like Human Agents: A Behavioral Approach to Bounded Rationality (1991)Competition, Innovation and Productivity Growth: A Review of Theory and Evidence (2002)Potential Savings from Substituting Generic Drugs for Brand-Name Drugs: Medical Expenditure Panel Survey, 1997–2000 (2005)Encouraging the use of generic medicines: implications for transition economies. (2002)The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugs (2003)Patients’ attitudes towards and experiences of generic drug substitution in Norway (2006)The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians (2015)The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending (2003)Prescription drug cost sharing: associations with medication and medical utilization and spending and health. (2007)Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease (2008)Exploring Generic Drug Use Behavior (2002)An empirical model of learning and patient spillovers in new drug entry (2003)Financial incentives and physicians’ prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan (2008)Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey (2009)Cancer Therapy Costs Influence Treatment: A National Survey Of Oncologists (2010)Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They Implant (2014)
this work references cited by second hop

References

  • 1998The Importance of the Physician in the Generic versus Trade-Name Prescription Decision300 cited
  • 1991The doctor as double agent: Information asymmetry, health insurance, and medical care280 cited
  • 1988Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals254 cited
  • 2000Physicians' Attitudes About Prescribing and Knowledge of the Costs of Common Medications204 cited
  • 2000Moral hazard in physician prescription behavior164 cited
  • 2000The Importance of Doctors’ and Patients’ Preferences in the Prescription Decision142 cited
  • 1999Financial Incentives And Drug Spending In Managed Care137 cited

Cited by

  • 2015Improving Adherence to Therapy and Clinical Outcomes While Containing Costs: Opportunities From the Greater Use of Generic Medications: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians95 cited
  • 2009Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization?87 cited
  • 2010Evaluating pharmacists’ views, knowledge, and perception regarding generic medicines in New Zealand82 cited
  • 2007What’s in a Name? Use of Brand versus Generic Drug Names in United States Outpatient Practice79 cited
  • 2010A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance78 cited
  • 2014Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

74 cited
  • 2012Exploring the impact of operating model choice on the governance of inter-organizational workflow: the U.S. e-prescribing network26 cited